Abstract
Angiogenesis is one important hallmark of cancer progression which explains the relevance of developing methods to efficiently analyze the neo-angiogenic process. In this report we make use of the transgenic adenocarcinoma of the murine prostate (TRAMP) model, considered a good model for studying clinical prostate cancer progression, to describe in detail the methods used to study angiogenesis in this type of solid tumor development. In this report we provide step-by-step procedures on the basis of previous work in our laboratory for: the mouse urogenital sinus (UGS) collection; microdissection of the prostate; preparation of the prostatic samples for immunofluorescence (to analyze vascular density, morphology, maturation, functionality, hypoxia, and others); preparation of prostatic samples to histopathological analysis and/or immunohistochemistry; and endothelial and vascular mural cell sorting and isolation by fluorescent associated cell sorting (FACS) to further analysis (mRNA, protein, or other) or to maintain in culture.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
World Health Organization (2014) World cancer report, 2014, WHO report. WHO, Geneva
Taylor RA, Toivanen R, Risbridger GP (2010) Stem cells in prostate cancer: treating the root of the problem. Endocr Related Cancer 17:R273–R285
Hayward SW, Rosen MA, Cunha GR (1997) Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol 79(Suppl 2):18–26
Russo G, Mischi M, Scheepens W et al (2012) Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int 110:E794–E808
Borre M, Offersen BV, Nerstrøm B et al (1998) Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 78:940–944
Bono AV, Celato N, Cova V et al (2002) Microvessel density in prostate carcinoma. Pros Cancer Pros Dis 5:123–127
Papetti M, Herman IM (2002) Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282:C947–C970
Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate-cancer in a transgenic mouse. Proc Natl Acad Sci U S A 92:3439–3443
Cunha GR, Donjacour AA, Cooke PS et al (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8:338–362
Berquin IM, Min Y, Wu R et al (2005) Expression signature of the mouse prostate. J Biol Chem 280:36442–36451
Kaplan-Lefko PJ, Chen T-M, Ittmann MM et al (2003) Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55:219–237
Gratton JP, Lin MI, Yu J et al (2003) Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 4:31–39
Pedrosa A-R, Trindade A, Carvalho C et al (2015) Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. Oncotarget 6:24404–24423
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pedrosa, AR., Trindade, A., Duarte, A. (2018). Methods to Study Angiogenesis in a Mouse Model of Prostate Cancer. In: Culig, Z. (eds) Prostate Cancer. Methods in Molecular Biology, vol 1786. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7845-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7845-8_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7843-4
Online ISBN: 978-1-4939-7845-8
eBook Packages: Springer Protocols